Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Florian Brand

Recent news which mentions Florian Brand

Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags Srinivas Rao Benzinga ATAI Life Sciences
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
Tickers ATAI CMPS
Tags Psychedelics Florian Brand Penny Stocks
From Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
Tickers ATAI
Tags Psychedelics Florian Brand clinical trial
From Benzinga
Novel Psychedelic Compound Show Positive Results For Opioid Use Disorder Treatment
Tickers ATAI
Tags Management News Kures
From Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Tickers ATAI HTGC
Tags Srinivas Rao Management News
From Benzinga
Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader
Tickers ATAI
Tags Sector ETFs Market News Mid Cap
From Benzinga
EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development
Tickers ATAI
Tags News Srinivas Rao/ Market News
From Benzinga
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
Tickers ATAI JNJ
Tags Florian Brand ATAI Perception Neuroscience
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.